Lotus Pharms Inc (LTUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2017 | 12-2010 | |
| Sales | 0 | 0 | 0 | 0 | 72,690 |
| Cost of Goods | N/A | N/A | N/A | N/A | 32,910 |
| Gross Profit | N/A | N/A | N/A | N/A | 39,780 |
| Operating Expenses | 0 | 0 | 0 | 0 | 19,390 |
| Operating Income | N/A | N/A | N/A | N/A | 21,300 |
| Interest Expense | 0 | 0 | 0 | 0 | 610 |
| Other Income | 0 | 0 | 0 | 0 | -6,050 |
| Pre-tax Income | 0 | 0 | 0 | 0 | 14,640 |
| Income Tax | N/A | N/A | N/A | N/A | 220 |
| Net Income Continuous | 111 | -19 | -24 | N/A | 21,188 |
| Net Income | $111 | $-19 | $-24 | $N/A | $14,420 |
| EPS Basic Total Ops | 0.00 | 0.00 | 0.00 | N/A | 0.55 |
| EPS Basic Continuous Ops | 0.00 | 0.00 | 0.00 | N/A | 0.81 |
| EPS Diluted Total Ops | 0.00 | 0.00 | 0.00 | N/A | 0.54 |
| EPS Diluted Continuous Ops | 0.00 | 0.00 | 0.00 | N/A | 0.78 |
| EBITDA(a) | $N/A | $N/A | $N/A | $N/A | $23,750 |